Harvard Bioscience Shares Plunge, Molecular Devices Up

With shares of Harvard Bioscience dropping 13 percent, and Bio-Rad falling 11 percent, the BioCommerce Week Index this week ended down for the third time in the last four weeks.

Harvard Bioscience has lost 19 percent of its market capitalization in the last two weeks while Bio-Rad saw a 9-percent gain last week reversed this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.